28 May, 2025 in Investor Relations Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on June 3
06 May, 2025 in Investor Relations Nexalin Technology Announces Closing of Previously Announced $5.0 Million Underwritten Public Offering
05 May, 2025 in Investor Relations Nexalin Technology Announces Pricing of $5.0 Million Public Offering of Common Stock
01 May, 2025 in Investor Relations Nexalin Technology Initiates FDA Q-Submission Process for Gen-2 SYNC Following Encouraging Data and Preliminary FDA Feedback
